A Trial to Evaluate Efficacy and Safety of Lenvatinib in Combination With Everolimus in Subjects With Unresectable Advanced or Metastatic Non Clear Cell Renal Cell Carcinoma (nccRCC) Who Have Not Received Any Chemotherapy for Advanced Disease
Clinical trial NCT02915783 · COMPLETED
Trial details
- NCT number
- NCT02915783
- Sponsor
- Eisai Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-20
- Primary completion
- 2021-11-02
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.